Astel­las finds an­oth­er col­lab­o­ra­tor in small UK start­up; Two Japan­ese biotechs align on gene ther­a­pies

Af­ter an im­muno-on­col­o­gy an­ti­body deal,  a can­cer im­munother­a­py tie-up and a pro­tein pact, Astel­las Phar­ma is on to its next part­ner­ship, this time with a small UK biotech to treat eye dis­eases.

The Japan­ese phar­ma will team up with Mo­gri­fy to find in vi­vo re­gen­er­a­tive med­i­cine ap­proach­es to treat­ing sen­sorineur­al hear­ing loss. The goal is to find new com­bi­na­tions of tran­scrip­tion fac­tors to help de­vel­op new cochlear hair cells.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER